Abstract
Synthetic biology is a recent scientific approach towards engineering biological systems from both pre-existing and novel parts. The aim is to introduce computational aided design approach in biology leading to rapid delivery of useful applications. Though the term reprogramming has been frequently used in the synthetic biology community, currently the technological sophistication only allows for a probabilistic approach instead of a precise engineering approach. Recently, several human health applications have emerged that suggest increased usage of synthetic biology approach in developing novel drugs. This mini review discusses recent translational developments in the field and tries to identify some of the upcoming future developments.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agustín-Pavón C, Isalan M (2014) Synthetic biology and therapeutic strategies for the degenerating brain: synthetic biology approaches can transform classical cell and gene therapies, to provide new cures for neurodegenerative diseases. Bioessays 36:979–990
Baulard AR, Betts JC, Engohang-Ndong J, Quan S, McAdam RA, Brennan PJ, … Besra GS (2000) Activation of the pro-drug ethionamide is regulated in mycobacteria. J Biol Chem 275(36):28326–28331
Benner SA, Sismour AM (2005) Synthetic biology. Nat Rev Genet 6(7):533–543
Chakravarti D, Wong WW (2015) Synthetic biology in cell-based cancer immunotherapy. Trends Biotechnol 33(8):449–461
Coppola M, van den Eeden SJ, Wilson L, Franken KL, Ottenhoff TH, Geluk A (2015) Synthetic long peptide derived from M. tuberculosis latency antigen Rv1733c protects against tuberculosis. Clin Vaccine Immunol. 2015 Jul 22. pii:CVI.00271-15
Covello, Patrick S (2008) Making artemisinin. Phytochemistry 69(17):2881–2885
Dhar PK, Thwin CS, Tun K, Tsumoto Y, Maurer-Stroh S, Eisenhaber F, Surana U (2009) Synthesizing non-natural parts from natural genomic template. J Biol Eng 3(1):2
Engohang-Ndong J, Baillat D, Aumercier M, Bellefontaine F, Besra GS, Locht C, Baulard AR (2004) EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator. Mol Microbiol 51(1):175–188
Fong H, Wang C, Knoferle J, Walker D (2013) Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells. Stem Cell Rep 1:226–234
Garriga-Canut M, Agustin-Pavon C, Herrmann F, Sanchez A (2012) Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6/2 mice. Proc Natl Acad Sci USA 109:E3136–E3145
Global Tuberculosis Report, World Health Organization, 2014. ISBN 9789241564809
Hale V, Keasling JD, Renninger N, Diagana TT (2007) Microbially derived artemisinin: a biotechnology solution to the global problem of access to affordable antimalarial drugs. Am J Trop Med Hyg 77(6 Suppl):198–202
Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA (2003) Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 60(8):1119–1122
Hobom B (1980) Gene surgery: on the threshold of synthetic biology. Medizin Klinik 75(24):834–841
Laganiere J, Kells AP, Lai JT, Guschin D (2010) An engineered zinc finger protein activator of the endogenous glial cell line-derived neurotrophic factor gene provides functional neuroprotection in a rat model of Parkinson’s disease. J Neurosci 30:16469–16474
Paddon CJ, Keasling JD (2014) Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development. Nat Rev Microbiol 12(5):355–367
Raj N, Helen A, Manoj N, Harish G, Thomas V, Singh S, Sehrawat S, Seth S, Nair As, Grover A, Dhar PK (2015) In silico study of peptide inhibitors against BACE 1. Syst Synth Biol 9:67–72
Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, … Keasling JD (2006) Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440(7086):940–943
Rosendahl Huber SK, Camps MG, Jacobi RH, Mouthaan J, van Dijken H, van Beek J, Ossendorp F, de Jonge J (2015) Synthetic long peptide influenza vaccine containing conserved T and B cell epitopes reduces viral load in lungs of mice and ferrets. PLoS One 10(6):e0127969
Saxena A, Mukherjee U, Kumari R, Singh P, Lal R (2014) Synthetic biology in action: developing a Drug against MDR-TB. Indian J Microbiol 54:369–375
Shankar S, Pillai MR (2011) Translating cancer research by synthetic biology. Mol Biosyst 7(6):1802–1810
Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65(1):5–29
Soldner F, Laganiere J, Cheng AW, Hockemeyer D (2011) Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 146:318–331
Weber W, Schoenmakers R, Keller B, Gitzinger M, Grau T, Daoud-El Baba M, Sander P, Fussenegger M (2008) A synthetic mammalian gene circuit reveals antituberculosis compounds. PNAS 105(29):9994–9998
www.gatesfoundation.org/Media-Center/Press-Releases/2008/03/Malaria-Partners-Letter
Yagi H, Tan W, Dillenburg-Pilla P, Armando S, Amornphimoltham P, Simaan M, Weigert R, Molinolo AA, Bouvier M, Gutkind JS (2011) A synthetic biology approach reveals a CXCR4-G13-Rho signaling axis driving transendothelial migration of metastatic breast cancer cells. Sci Signal 4(191):ra60
Yan R, Vassar R (2014) Targeting the β secretase BACE1 for Alzheimer’s disease therapy. Lancet Neurol 13(3):319–329
Acknowledgments
We are thankful to Symbiosis Centre for Research and Innovation (SCRI), Symbiosis International University (SIU), Lavale, Pune, India for providing Ph.D. fellowship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Singh, M., Vaidya, A. Translational synthetic biology. Syst Synth Biol 9, 191–195 (2015). https://doi.org/10.1007/s11693-015-9181-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11693-015-9181-y